Mental and Cognitive Health and Physical Activity in the Perioperative Breast Cancer Setting

CompletedOBSERVATIONAL
Enrollment

42

Participants

Timeline

Start Date

March 10, 2022

Primary Completion Date

June 23, 2023

Study Completion Date

June 23, 2023

Conditions
Breast CancerBreast NeoplasmsCancer, BreastCancer of the Breast
Interventions
OTHER

Actigraph

Participants will wear an Actigraph hip-worn accelerometer on their non-dominant hip during all waking hours, and on the wrist while sleeping

OTHER

Questionnaires

"* Patient Health Questionnaire Anxiety and Depression Scale30 (PHQ-ADS), a validated composite of anxiety and depressive symptoms.~* Self-reported cognition will be assessed by the Functional Assessment of Cancer Therapy-Cognitive (FACT-Cog)."

OTHER

BrainBaseline application

Objective measures of cognitive function will include those from the BrainBaseline application, a validated research tool developed by Digital Artefacts to remotely measure domains of cognition

OTHER

Semi-structured interviews

Semi-structured individual interviews will be conducted with up to 15 healthcare stakeholders and 15-30 patients with breast cancer at any time during the study period, as determined by participant preference.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Washington University School of Medicine

OTHER

NCT06595901 - Mental and Cognitive Health and Physical Activity in the Perioperative Breast Cancer Setting | Biotech Hunter | Biotech Hunter